Malignant Nasopharyngeal Neoplasm — Trials

Malignant Nasopharyngeal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 261
Recruiting: 139
Ph III recruiting: 56
Growth YoY: +5.2%
Industry share: 9%
Top sponsor: Sun Yat-sen University
Termination share: 24.1%
Trials / 1,000 deaths: 376.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 151–166 of 166 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02621970	Effect of Triple Combination of Induction, Concurrent and Adjuvant Chemotherapy in High Risk Nasopharyngeal Carcinoma	unknown	Phase 3	534	Sun Yat-sen UniversityOTHER	1	Dec 4, 2015	clinicaltrials
NCT02610010	Intensity-modulated Radiotherapy With or Without Concurrent Chemotherapy for Stage II Nasopharyngeal Carcinoma	unknown	Phase 3	462	Sun Yat-sen UniversityOTHER	1	Nov 20, 2015	clinicaltrials